Shares of DaVita Inc. /zigman2/quotes/204229673/composite DVA +1.52% advanced 2.48% to $90.45 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.12% rising 1.83% to 3,979.87 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.10% rising 1.40% to 31,581.28. This was the stock's fourth consecutive day of gains. DaVita Inc. closed $40.67 below its 52-week high ($131.12), which the company achieved on September 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Fresenius Medical Care AG & Co. KGaA ADR /zigman2/quotes/210057637/composite FMS +2.50% rose 1.07% to $17.05, Laboratory Corp. of America Holdings /zigman2/quotes/203174601/composite LH -0.08% rose 2.58% to $231.94, and Universal Health Services Inc. Cl B /zigman2/quotes/208539347/composite UHS -0.65% rose 4.83% to $100.88. Trading volume (653,193) remained 123,042 below its 50-day average volume of 776,235.